StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

RAPPBullishAnalyst Target Updateanalyst
Medium materiality5/10

Raymond James raises Rapport Therapeutics price target to $86 from $75

Oct 20, 2026, 2:24 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish analyst update, with substantial implied upside at the new target; treat the target as an opinion rather than a forecast.

AI summary

What happened, with direct paths to the underlying reporting

Raymond James raised its RAPP price target by about 15%. The new target is well above the posted price of $29.19, though this remains a single analyst opinion.

  • Target raised from $75 to $86.
  • Posted price: $29.19.

Key facts

  1. 01

    Target: $86

  2. 02

    Posted price: $29.19

  3. 03

    Analyst firm: Raymond James

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.